THE ANALGESIC INNOVATION TEAM
Get to Know Us
MARK J. FIELD PhD MSc (Neuroscience)
Owner / Founder
Neuroscientist with 30 years experience in pharmaceutical industry developing new pain medicines. Currently CEO of EptivA Therapeutics Ltd.
His focus has been on helping patients with chronic pain by identifying novel analgesics during a career working at large and mid size companies including: MSD, Parke-Davis, Pfizer, UCB and Grunenthal.
He is senior executive and a pioneer Translational Scientist with experience spanning both preclinical research and clinical development.
He has senior leadership experience at corporate level as Head of R&D Pain innovation with responsibility for; Strategy, people (~200) & budget (~€150M) to drive projects from research to clinical Phase III.
Mark's research has contributed to over 30 compounds moving from research ideas into projects entering clinical development and helped develop the novel blockbuster analgesic Pregabalin.
Mark's research is documented in over 100 full-length manuscripts, abstracts and patents with over 5000 citations
BETHANY HOPE FIELD BA (Hons)
Bethany has just completed her BA (Hons) degree in Fashion Promotion at Ravensbourne University, London.
She is responsible for the branding of Analgesic Innovation and has created images and graphical content used by Analgesic Innovation.
Bethany has previously been a graphic web designer for PIXEL, London and a Creative Assistant for VIOR Fashion Ltd.